期刊文献+

宫颈癌患者血清和组织中胰岛素样生长因子-Ⅱ的表达及临床意义 被引量:1

Variation of insulin-like growth factor Ⅱ in serum and tissue of patients with cervical cancer and its clinical significance
下载PDF
导出
摘要 目的检测宫颈癌患者血清胰岛素样生长因子-Ⅱ(IGF-Ⅱ)水平及其在肿瘤组织中的表达,探讨IGF-Ⅱ在宫颈癌发生、发展中的作用。方法采用放射免疫法检测血清IGF-Ⅱ水平,应用免疫组织化学方法检测IGF-Ⅱ在正常宫颈组织和宫颈癌组织中的表达情况,同时对组织中IGF-Ⅱ表达与宫颈癌各临床病理参数之间的关系进行分析。结果(1)宫颈癌组和对照组血清IGF-Ⅱ浓度分别为(1.98±0.53)和(0.51±0.16)μg/L,二者相比差异有统计学意义(P<0.01);宫颈癌患者治疗后血清IGF-Ⅱ浓度比治疗前明显降低,淋巴结转移组血清IGF-Ⅱ浓度为(2.26±0.32)μg/L,明显高于淋巴结未转移组(1.73±0.42)μg/L,差异有统计学意义(P<0.01)。(2)宫颈癌、正常宫颈组织中IGF-Ⅱ表达阳性率分别为73.3%和10.0%,二者相比差异有统计学意义(P<0.01)。IGF-Ⅱ的阳性表达与宫颈癌临床分期、分化程度呈显著相关,差异有统计学意义(P<0.01),其在淋巴结转移组的阳性表达率明显高于无淋巴结转移组(χ2=8.69,P<0.01)。结论IGF-Ⅱ的高表达与宫颈癌的发生、发展及侵袭转移有关,检测IGF-Ⅱ能为宫颈癌的临床诊断和预后观察提供有意义的参考。 Objective To investigate the expression of serum and tissue insulin-like growth factor Ⅱ (IGF-Ⅱ ) in patients with cervical cancer, and to evaluate its clincial significance in the ocuurence and development of cervical cancer. Methods The serum level of IGF- Ⅱ was examined by radioimmunoassay (RIA), and the expression level of IGF- Ⅱ in the tumor and normal tissue was detected with immunohistoehemical technique. The relationship of tissue expression level of IGF-Ⅱ and the clinicopathological parameters was analyzed as well. Results The serum IGF-Ⅱ levels in cervical cancer group and the control group were (1.98±0.53)μg/L and (0.5±0.16)μg/L, respectively. There was significant difference between them (P〈0.01) ; the serum IGF- Ⅱ level was decreased significantly after therapy. The serum IGF- Ⅱ level in lymph node metastasis group was obviously higher than that in lymph node nonmetastasis group [(2.26±0.32)μg/L vs (1.73±0.42) μg/L,P〈0.01]. The positive expression rate of IGF-Ⅱ in cervical cancer tissues was 73.3%, significantly higher than that in normal cervical tissues (10.0%) (P〈0.01). The positive expression of IGF- Ⅱ was closely correlated with different clinical stage and differentiation degree of carcinoma (P〈0.01). The positive expression rate of IGF-Ⅱ in lymph node metastasis group was significantly higher that in lymph node non-metastasis group (2 = 8.69, P〈0.01). Conclusion The excessive expression of IGF-Ⅱ may be correlated with the genesis, invasion and metastasis of cervical cancer. The expression of IGF- Ⅱ may be useful marker of diagnosis and prognosis evaluation of cervical cancer.
出处 《检验医学与临床》 CAS 2008年第22期1351-1352,共2页 Laboratory Medicine and Clinic
关键词 宫颈肿瘤 胰岛素样生长因子-Ⅱ 放射免疫法 免疫组织化学 cervix neoplasms insulin-like growth factorⅡ radioimmunoassay immunohistochemistry
  • 相关文献

参考文献5

  • 1陈照丽,王欣,黄秉仁.IGF系统的生物学功能及其与肿瘤的关系[J].国外医学(分子生物学分册),2003,25(1):34-37. 被引量:27
  • 2[2]LRoeith D,Roberts CT.The insulin-like growth factor system and cancer[J].Cancer Lett,2003,195 (2):127-137.
  • 3[3]Deming SL,Ren Z,Cai Q,et al.IGF-Ⅰ and IGF-Ⅱ genetic variation and breast cancer risk in Chinese women:results from the Shanghai Breast Cancer Study[J].Cancer Epidemiol Biomarkers Prey,2008,17 (1):255-257.
  • 4[4]Subbi P,Mathur SP,Rajesh S,et al.Circulating level of insulin-like growth factor-Ⅱand IGF-binding protein 3 in cervical cancer[J].Gynecol Oncol,2003,91(2):486-490.
  • 5[5]Sayer RA,Lancaster JM,Pit:man J,et al.High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer[J].Gynecol Oncol,2005,96(2):355-361.

二级参考文献16

  • 1[1]Eckhard Wolf et al. Growth Horm IGF Res,1998;8:185
  • 2[2]Valentinis B et al. J Biol Chem,1999;274:12423
  • 3[3]Gampbell PG et al.J Biol Chem,1999;274(42):30215
  • 4[4]Zumkeller W et al. Mol Pathol,2001;54(4):227
  • 5[5]Valentinis B et al. Mol Pathol,2001;54(3):133
  • 6[6]Blakesley VA et al. J Biol Chem,1998;273:18411
  • 7[7]Chen H et al .Cell Growth Differ,1998;9:939
  • 8[8]Dupont J et al. Mol Pathol,2001;54(3):149
  • 9[9]Vella V et al. Mol Pathol,2001;54(3):121
  • 10[10]Weber MM et al. Eur J Clin Invest,2000;30 Suppl 3:69

共引文献26

同被引文献25

  • 1Lu L, Katsaros D, Wiley A, et al. Promoter-specific transcription of insulin like-growth factor in epithelial ovarian cancer [ J ]. Gyneeol Oneol, 2006, 103(3) :990 -995.
  • 2Sachdev D, Yee D. Disrupting insulin-like growth factor signaling as a potential cancer therapy[ J]. Mol Cancer Ther,2007,6 : 1 - 12.
  • 3Shen MR, Hsu YM, Hsu KF, et al. Insulin like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling[ J ]. Carcinogene- sis,2006,27 ( 5 ) :962 - 971.
  • 4RC Barter. Signaling pathway involved in antiproliferative effects of IGFBP-3 : a review[ J]. Clin Pathol : Mol Patho1,2001,54 : 145 - 148.
  • 5Liu B, Lee K W, Anzo M, et al. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis [ J ]. Oncogene,2007,26 : 1811 - 1819.
  • 6Kawasaki T Nosho K Ohnishi M, et al. IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG Island methylator phenotype and p53 [ J ]. Neoplasia, 2007,9 ( 12 ) : 1091 - 1098.
  • 7Fu P, Thompson J A, Bach LA. Promotion of cancer cell migration : an insulin like growth factor (IGF) -independent action of IGF-bind- ing protein-6 [ J]. Biol Chem,2007,282 (31 ) :22298 - 22306.
  • 8Gotlied WH, Bruchim I, Gu J, et al. Insulin-like growth factor re- ceptor I targeting in epithelial ovarian cancer [J]. Gynecol Oncol, 2006,100(2) :389 -396.
  • 9Lukanova A, Lundin E, Toniolo P, et al. Circulating leveloinsulin-lik- growth factor-I and risk of ovarian Ccancer[ J ]. Int Cancer,2002,101 (6) :549-554.
  • 10Lu L, Katsaros D, Wiley A, et al. Promoter-specific transcription of insulin-like growth factor in epithelial ovarian cancer[J].Gynecol Oncol,2006,103 (3) :990 - 995.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部